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Background: Renal infarction (RI) is an uncommon disease that is difﬁcult to di-
agnose. As little is known about clinical characteristics of this disease, we investi-
gated its underlying risk factors and outcomes.
Methods: We performed a retrospective single-center study of 89 patients newly
diagnosed with acute RI between January 2002 and March 2015 using imaging
modalities. Clinical features, possible etiologies, and long-term renal outcome data
were reviewed.
Results: The patients' mean age was 63.5 ± 15.42 years; 23.6% had diabetes and
56.2% had hypertension. Unilateral and bilateral involvements were shown in 80.9%
and 19.1% of patients, respectively; proteinuria and hematuria were reported in
40.4% and 41.6%, respectively. Cardiovascular disease was the most common un-
derlying disease, followed by renal vascular injury and hypercoagulability disorder.
Fourteen patients had no speciﬁc underlying disease. At the time of diagnosis, acute
kidney injury (AKI) was found in 34.8% of patients. Univariate analysis revealed
diabetes mellitus (DM), leukocytosis, and high C-reactive protein (CRP) as signiﬁcant
risk factors for the development of AKI. On multivariate analysis, DM and high CRP
levels were independent predictors for AKI. During follow-up, chronic kidney dis-
ease developed in 27.4% of patients. Univariate and multivariate Cox regression
analyses showed old age to be an independent risk factor for this disease, whereas
AKI history was a negative risk factor.
Conclusion: DM patients or those with high CRP levels should be observed for renal
function deterioration. Clinicians should also monitor for RI in elderly patients.
Copyright © 2016. The Korean Society of Nephrology. Published by Elsevier. This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Renal infarction (RI) is an infrequent condition that is related
to atheroembolic or thromboembolic disease [1]. The ﬁrst case
of renal embolic disease was reported in 1856 [2], and severalternal Medicine, Korea
gbuk-gu, Seoul, Korea.
.
ty of Nephrology. Published b
/4.0/).more cases and clinical analyses have been published since.
Most reported cases have underlying causes, such as hyperco-
agulability, cardiac problems, trauma history, or previous ce-
rebral infarction [2e4]. Various comorbidities, such as
infection, malignancy, cocaine abuse, and autoimmune disease,
may also contribute to RI [5e9]. Abdominal or ﬂank pain is a
common clinical manifestation, although some patients do not
experience any subjective symptoms. Therefore, RI is difﬁcult to
detect unless a clinician speciﬁcally checks for its presence and
is thus likely to be underdiagnosed [1,3,4,10e12]. Postmortemy Elsevier. This is an open access article under the CC BY-NC-ND license
Renal infarction 
89 patients 
Non-AKI 58 patients 
(including nondialysis 
CKD 9) 
CKD 
(eGFR <60 after 6 mo) 
16/59 patients 
AKI 
31 patients 
(RIFLE criteria  
risk 17, injury 8, failure 1) 
 30 were excluded: 
  6 Lost to follow-up or missing data 
  4 Transferred out  
  3 Self-discharged 
  1 Pancreatic cancer 
  1 Breast cancer 
  1 Bladder cancer 
  1 Myelodysplastic syndrome 
  1 Intracranial hemorrhage 
3 Sepsis 
  9 CKD (baseline eGFR <60) 
Figure 1. Flowchart of patient outcome.
AKI, acute kidney injury; CKD, chronic kidney disease; eGFR, estimated
glomerular ﬁltration rate; RIFLE, Risk, Injury, Failure, Loss, and End-stage
kidney disease.
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1.4% (205 of 14,411) with only 2 of these cases having been
clinically diagnosed antemortem [13]. Another study reported
an RI incidence of 0.007% during a 36-month observation
period [14].
With the advent of innovative imaging technologies, inci-
dental RI cases are detected more frequently [4]. Improved
accessibility to contrast-enhanced computed tomography can
also reveal more RI cases. Nowadays, RI can be detected in
patients who visit hospitals with nonspeciﬁc symptoms and no
demonstrable underlying causes.
A partial RI animal model induced by renal artery ligation
revealed increased plasma renin activity and development of
hypertension [15], but there are no ﬁrm data regarding long-
term follow-up results in patients after RI. Reduced kidney
blood ﬂow and mass reduction can cause deterioration of renal
function, although hyperperfusion of the viable renal glomeruli
can compensate for this [1]. In this context, RI may be thought
of as a completely reversible disease. However, there are also
patients who progress to a state where they require dialysis [8].
The purpose of this study was 2-fold. First, we aimed to
reveal the clinical etiology and characteristics of RI. Second, we
investigated the acute and long-term changes in renal function
due to RI and determined the factors associated with renal
functional deterioration.
Methods
Patients
This was a retrospective, single-center study of 89 patients
newly diagnosed with acute RI between January 2002 and
March 2015. Diagnosis was based on a radiologist's report of
imaging modalities, such as computed tomography, sonogra-
phy, and angiography. Patients who visited the emergency
department or underwent imaging studies during hospitaliza-
tion were included. The creatinine level measured 7e365 days
before the study was considered as the baseline value [16]. If
there were no preexisting creatinine data, baseline creatinine
was regarded as the healthiest creatinine level measured. Pa-
tients younger than 18 years were excluded. Clinical manifes-
tations and possible etiologies were extracted from initial
emergency room medical records or admission notes. We used
the Risk, Injury, Failure, Loss, and End-stage kidney disease
criteria to deﬁne acute kidney injury (AKI) as measured by a
change in serum creatinine levels within 1e7 days from the
initial renal insult [17]. Development of chronic kidney disease
(CKD) was deﬁned as a creatinine-based estimated glomerular
ﬁltration rate (eGFR) < 60mL/min/1.73 m2 over 3 months using
the Modiﬁcation of Diet in Renal Disease equation [18]. For
long-term outcome analysis, we excluded patients whose
eGFRs were < 60 mL/min/1.73 m2 at baseline. Patients who
have more than 1 underlying medical condition were assessed
by using Charlson comorbidity index (CCI) score [19]. This
study was approved by the Korea University Anam Hospital
Institutional Review Board (2015-04-0345).
Statistical analysis
The IBM SPSS statistics software, version 20 (IBM analytics,
Chicago, IL, USA) was used for statistical analyses. Comparison
between 2 groups was performed using the t test for numericaldata and the chi-square test or Fisher exact test for categorical
data. Univariate logistic tests were conducted for AKI and RI.
Results that followed normal distribution were presented as
mean values. In contrast, if the results did not follow normal
distribution, the median value was used. We used multivariate
Cox regression tests to identify predictors of long-term
decreased renal function because of RI diagnosis. All de-
mographic factors, comorbidities, laboratory data, treatment
options, and ﬁrst manifestations of symptoms were included in
the list of possible risk factors for decreasing renal function.
Results
A total of 89 acute RI patients were identiﬁed during the
13 years. The mean follow-up period was 33.45 ± 29.04months
with a maximum of 119 months. Six patients had no medical
record because of discharge or follow-up loss (Fig. 1). Four
patients transferred to another hospital before 3 months had
died, whereas 3 patients were excluded from the analysis of
long-term renal function because of self-discharge. Five pa-
tients died of pancreatic cancer, breast cancer, bladder cancer,
myelodysplastic syndrome, and intracranial hemorrhage,
respectively, whereas 3 patients died of sepsis. Nine patients
exhibited reduced renal function at the ﬁrst follow-up time
point with an eGFR below 60 mL/min/1.73 m2. Hence, 59 pa-
tients were ultimately included for analysis of the long-term
change in renal function at 1 year or more after RI diagnosis.
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diagnosis (Table 1). According to the Risk, Injury, Failure, Loss,
and End-stage kidney disease criteria, 17 (19.7%) patients were
at risk, 8 (9.3%) patients had injury, and 1 (1.1%) patient had
kidney failure. AKI patients were older than those without AKI,
although the difference was not signiﬁcant. More AKI patients
had diabetes mellitus (DM) (P¼ 0.010), were current or former
smokers (P ¼ 0.010), showed more hematuria (P ¼ 0.020), and
had lower baseline eGFR (P ¼ 0.050), severe leukocytosis
(P ¼ 0.010), and higher C-reactive protein (CRP) levels
(P ¼ 0.010). Cardiovascular disease was the most common risk
factor (38.2%), followed by renal vascular injury and hyper-
coagulability disorder (14.6% and 3.4%, respectively). Hyper-
coagulability conditions included 1 antiphospholipid
syndrome patient and 2 loweprotein C patients. Cardiovas-
cular diseases included atrial ﬁbrillation (22; 24.7%), valvular
heart disease (4; 4.4%), endocarditis (4; 4.4%), stable angina (3;
3.3%), and pulmonary thromboembolism (1; 1.1%). We also
observed additional comorbidities that may be risk factors forTable 1. Baseline characteristics of renal infarction patients in the AKI v
Total (n ¼ 89)
Age, median (minimumemaximum) 60.9 (21.0e87.
Male 53.0 (59.6)
DM 21.0 (23.6)
Hypertension 50.0 (56.0)
Smoking 37.0 (41.6)
BMI (kg/m2) 23.5 (13.0e32
Proteinuria 36.0 (40.4)
Hematuria 37.0 (41.6)
Baseline eGFR, median (minimumemaximum) 80.7 (26.2e17
Risk factors
Cardiovasculary 34.0 (38.2)
Coagulation 3.0 (3.4)
Renal vascular injury 13.0 (14.6)
Other conditionsz 45.0 (50.6)
Idiopathic 10.0 (11.2)
CCI 2.0 (0.0e10.0
Combined other organ infarction 10.0 (11.2)
Bilateral involvement 30.0 (33.7)
Treatment option
Antiplatelet alone 11.0 (12.3)
Anticoagulation alone 18.0 (20.2)
ASA þ WFR 36.0 (40.4)
Thrombolysis 2.0 (2.2)
Symptoms
Abdominal pain 37.0 (41.6)
Flank pain 13.0 (14.6)
Fever 9.0 (10.1)
Nausea 1.0 (1.1)
Dyspnea 3.0 (3.4)
No symptoms 23.0 (25.8)
WBC 10,239 ± 6,376
Hb, median (minimumemaximum) 13.1 (7.1e21.7
Plt(k), median (minimumemaximum) 212.0 (16.0e48
CRP 61.3 ± 71.9
LDH 1,104 ± 826
HDL, median (minimumemaximum) 41.0 (10.0e83
LDL, median (minimumemaximum) 90.0 (29.0e29
Uric acid, median (minimumemaximum) 4.8 (2.2e7.5)
Total calcium, median (minimumemaximum) 8.8 (7.4e10.5
Data are presented as means ± SD or number (%).
* P < 0.05.
y Cardiovascular conditions include atrial ﬁbrillation, valvular heart disease,
z Other conditions include cerebral infarction, cerebral hemorrhage, cancer,
ulcer perforation, postoperative state, adult Still's disease, glomerulonephritis
abscess, systemic lupus erythematosus, and schizophrenia.
AKI, acute kidney injury; ASA, aspirin; BMI, body mass index; CCI, Charlson c
estimated glomerular ﬁltration rate; Hb, hemoglobin; HDL, high-density lipo
platelet; WBC, white blood cell; WFR, warfarin.thromboembolism associated with RI (provided in the foot-
note of Table 1). Moreover, 10 (11.2%) of the cases were idio-
pathic. The average CCI that represents the comorbid
condition was 2. Abdominal pain was the most frequently
experienced symptom (41.6%), whereas 25.8% of patients were
asymptomatic. We observed synchronous infarctions of other
organs in 10 (11.2%) patients; the most common site was the
spleen (5 splenic infarctions and 1 segmental splenic infarc-
tion with descending colon infarction) followed by combined
bowel ischemia (2 diffuse ischemic colitis and 2 small bowel
ischemia cases). Bilateral renal artery involvement was
observed in 30 (33.7%) patients. Regarding treatment, anti-
platelet therapy, anticoagulation, and thrombolysis (for un-
controlled abdominal pain) were administered to 47 (52.8%),
54 (60.7%), and 2 (2.2%) patients, respectively. Incidences of
DM, malignancy, and AKI; CCI score; and CRP levels were
signiﬁcantly different in the patients who were excluded from
CKD analysis (Table 2). Initial CKD patients were older, had
lower baseline eGFR, and had a higher smoking rate (Table 3).ersus non-AKI groups
AKI (n ¼ 31) Non-AKI (n ¼ 58) P
0) 60.0 (21.0e84.0) 68.0 (25.0e87.0) 0.070
21.0 (67.7) 32.0 (55.2) 0.370
13.0 (38.5) 8.0 (18.3) 0.010*
15.0 (48.4) 23.0 (39.7) 0.530
16.0 (51.6) 21.0 (36.2) 0.010*
.0) 24.0 (13.0e32.0) 24.0 (15.0e31.0) 0.840
14.0 (46.1) 22.0 (37.9) 0.490
18.0 (58.1) 19.0 (32.6) 0.020*
7.8) 84.4 (35.0e177.8) 75.8 (26.2e119.0) 0.010*
10.0 (32.3) 24.0 (41.3) 0.740
1.0 (3.2) 2.0 (3.4) 0.950
4.0 (12.9) 9.0 (15.5) 0.730
20.0 (64.5) 25.0 (43.1) 0.250
2.0 (6.7) 8.0 (13.6) 0.480
) 2.0 (0e10.0) 1.0 (0e9) 0.320
5.0 (16.1) 5.0 (8.6) 0.310
6.0 (20.0) 24.0 (80.0) 0.540
6.0 (19.3) 5.0 (8.6) 0.180
4.0 (12.9) 14.0 (24.1) 0.270
10.0 (32.3) 26.0 (44.8) 0.260
1.0 (3.2) 1.0 (1.7) 0.950
10.0 (32.3) 27.0 (46.5) e
4.0 (12.9) 9.0 (15.5) e
2.0 (6.4) 4.0 (6.8) e
0 1.0 (1.7) e
1.0 (3.2) 2.0 (3.4) e
5.0 (16.1) 18.0 (31.1) e
12,963 ± 8,962 8,675 ± 3,485 0.010*
) 14.0 (8.0e21.7) 13.0 (7.1e18.0) 0.930
4.0) 207.0 (16.0e484.0) 190.0 (16.0e363.0) 0.460
108.9 ± 79.9 35.2 ± 51.6 0.010*
1,211 ± 896 1,035 ± 784 0.430
.0) 41.5 (10.0e83.0) 41.0 (12.0e63.0) 0.770
6.0) 91.0 (36.0e296.0) 87.5 (29.0e162.0) 0.960
4.6 (2.2e7.5) 5.2 (2.8e7.4) 0.430
) 8.8 (7.4e10.5) 8.8 (7.7e10.1) 0.820
endocarditis, stable angina, and pulmonary thromboembolism.
rheumatoid arthritis, alcoholic hepatitis, Grave's disease, malaria, gastric
, polycystic kidney disease, long QT syndrome, nephrotic syndrome, renal
omorbidity index; CRP, C-reactive protein; DM, diabetes mellitus; eGFR,
protein; LDH, lactate dehydrogenase; LDL, low-density lipoprotein; Plt,
Table 2. Clinical characteristics of excluded patients
Included patients (n ¼ 51) Excluded patients (n ¼ 38) P
Age; median (minimumemaximum) 59 (21e84) 67 (32e87) 0.100
Baseline eGFR 80.0 (26.0e125.9) 79.3 (31.0e119.1) 0.290
DM 6 (12.0) 15 (39.5) 0.005*
Malignancy 0 (0) 16 (42.1) < 0.001*
AKI 14 (27.5) 17 (44.7) 0.177
CCI 1.0 ± 1.0 3.7 ± 2.0 < 0.001
CRP 36.4 ± 63.8 78.6 ± 72.4 0.005
WBC 8,700 (1,500e23,700) 9,155 (1,900e48,410) 0.210
Data are presented as means ± SD or number (%).
* P < 0.05.
AKI, acute kidney injury; CCI, Charlson comorbidity index; CRP, C-reactive protein; DM, diabetes mellitus; eGFR, estimated glomerular ﬁltration rate;
WBC, white blood cell.
Table 3. Clinical characteristics of patients with underlying CKD whose eGFRs were < 60 mL/min/1.73 m2
Initial with CKD (n ¼ 9) Initial without CKD (n ¼ 80) P
Age; median (minimumemaximum) 68 (44e83) 60 (21e87) 0.001*
Baseline eGFR 45.5 ± 10.9 94.1 ± 44.1 < 0.001*
Smoking 6 (66.7) 25 (34.2) 0.040
AKI 4 (44.4) 27 (33.7) 0.190
Data are presented as means ± SD or number (%).
* P < 0.05.
AKI, acute kidney injury; CKD, chronic kidney disease; eGFRs, estimated glomerular ﬁltration rates.
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and leukocytosis (P ¼ 0.007) showed a signiﬁcant relationship
with AKI (Table 4). On multivariate analysis, DM (hazard ratio
[HR], 4.424; P¼ 0.023) and high CRP level (HR,1.016; P¼ 0.008)
were independent risk factors for AKI (Table 4). CKD developed
in 16 cases (27.1%) during the follow-up period. None of the 59
patients who were initially non-CKD required renal replace-
ment therapy. On univariate Cox regression analysis, old ageTable 4. Univariate and multivariate logistic regression analyses of
risk factors associated with AKI in renal infarction patients
Variable Odds ratio 95% CI P (uni) P (multi)
Age 1.027 0.990e1.065 0.070 0.156
Sex 0.632 0.177e2.255 0.951 e
DM 3.305 1.054e10.366 0.005* 0.040*
HTN 1.386 0.574e3.345 0.468 e
Smoking 7.879 0.776e4.553 0.164 e
CRP 1.011 1.003e1.018 0.001* 0.004*
WBC 1.000 1.000e1.000 0.015* 0.160
* P < 0.05.
AKI, acute kidney injury; CI, conﬁdence interval; CRP, C-reactive protein;
DM, diabetes mellitus; HTN, hypertension; multi, multivariate analysis;
WBC, white blood cell; uni, univariate analysis.
Table 5. Univariate and multivariate Cox regression analyses of risk
factors associated with eGFR decreasing to< 60mL/min/1.73 m2 after
1 year in renal infarction patients
Variable Odds ratio 95% CI P (uni) P (multi)
Age 1.085 1.026e1.148 0.004* 0.017*
Sex 0.958 0.318e2.884 0.939 e
DM 0.645 0.208e1.997 0.447 e
HTN 0.407 0.124e1.337 0.138 0.061
Comorbidities 1.872 0.909e3.856 0.076 0.063
AKI history 0.161 0.034e0.763 0.021* 0.014*
* P < 0.05.
AKI, acute kidney injury; CI, conﬁdence interval; DM, diabetes mellitus;
eGFR, estimated glomerular ﬁltration rate; HTN, hypertension; multi,
multivariate analysis; uni, univariate analysis;multi, multivariate analysis.(HR, 1.085; P ¼ 0.004) was an independent predictor for eGFR
decline (Table 5). We divided RI patients into 2 groups: one
including those older than 60 years with an annual eGFR
decrease of 1.416 ± 5.35 mL/min/1.73 m2 and the other of pa-
tients younger than 60 years with eGFR decreasing at a rate of
1.16 ± 7.92 mL/min/1.73 m2. AKI history showed an indepen-
dent negative relationship with CKD development on univari-
ate Cox regression analysis (P ¼ 0.021), although the odds ratio
was 0.161, indicating that RI patients who experienced AKI
showed less severe long-term renal outcomes. Multivariate
analysis consistently showed that advanced age was a signiﬁ-
cant independent risk factor for CKD progression (P ¼ 0.017).
On multivariate analysis, AKI history also showed similar sig-
niﬁcance (P ¼ 0.014; Table 5).
Discussion
One-third of RI patients in our study showed AKI on initial
presentation, and a quarter subsequently developed CKD. Most
patients had speciﬁc clinical manifestation of symptoms on
initial presentation. No deceased or end-stage renal disease
patients required renal replacement therapy because of RI. DM
and high CRP levels were risk factors for AKI; moreover,
although old age was a risk factor for CKD, a history of AKI
showed a protective effect.
A high CRP level was an independent risk factor for AKI after
RI. CRP is indicative of a systemic inﬂammatory burden and
local tissue injury. CRP is also used as an inﬂammatory marker
in various other diseases [20e22]. It can cause secondary sys-
tematic inﬂammation and tissue damage owing to its induction
of cytokines [20]. The high level of CRP may reﬂect the pro-
portion of renal damage caused by RI; as CRP levels can directly
reﬂect the level of destruction to the renal parenchyma, it can
be used as a marker of reduced kidney function.
Patients with DM may experience more severe renal func-
tion degeneration on acute presentation. DM remains an in-
dependent predictor for AKI in RI patients, even after adjusting
Kidney Res Clin Pract 35 (2016) 90e9594for the CRP level. Underlying diabetes is one of the risk factors
of poor outcome in many diseases [23e26]. Insulin resistance
can cause severe metabolic derangement and poor outcome,
whereas metabolic dysregulation in DM patients, linked with
sustained systemic inﬂammation [27], can causemacrovascular
and microvascular damage. Such vulnerable vasculature can
lead to ischemic insult and subsequently to severe functional
deterioration.
Old age was an independent predictor for CKD. Decline in
renal function begins after the fourth decade, and the slope of
creatinine clearance approaches e1.24 ± 0.3 in normal healthy
subjects older than 60 years [28]. Individual glomeruli deteri-
orate functionally and structurally, and such loss of renal mass
with aging results in a decreased eGFR. A preexisting aging-
related decrease in renal function combined with a new
insult caused by RI inevitably leads to a poor and irreversible
outcome.
Reversible AKI is a risk factor for de novo CKD, mortality, and
it is connected with the severity [29e31]. In contrast, we found
that AKI with RI was negatively related to CKD progression. The
long-term analysis was only conducted with patients who
survived. As we discussed in Table 2, excluded patients expe-
rienced more AKI, but they are not tracked and dead. They
showed higher incidence of DM, malignancy, and upper CCI
score. This speciﬁcity might contribute to fetal outcome. On the
other hand, patients with a history of AKI may undergo more
intensive monitoring and thus be at lower risk of developing
CKD. We found small differences on detailed subanalysis that
were not detected during overall analysis. Patients who expe-
rienced AKI without CKD development have more cardiogenic
risk factors (59% vs. 32.8%, respectively; P¼ 0.040) and a higher
DM incidence (45.5% vs. 16.7%, respectively; P ¼ 0.010) than
those who developed no CKD. A greater proportion had also
undergone combined antiplatelet and anticoagulation therapy,
although the difference was not statistically signiﬁcant (46.3%
vs. 22.7%, respectively; P ¼ 0.070). Patients at risk who develop
AKI should consider dual-agent therapy to prevent CKD.
According to Oh et al [32] and Bae et al [33], cardiogenic risk
factors, especially atrial ﬁbrillation, are a main cause of RI. We
found cardiogenic etiologies to be the most common single
cause of RI (38.2% of cases). We investigated an expanded list of
factors that play a role in systemic inﬂammation as well as
vascular and/or coagulation disorders that may lead to infarc-
tion. Various conditions were incorporated into the CCI; how-
ever, CCI did not show a signiﬁcant relationship with AKI or
CKD development.
Infarctions in other organs that were observed in 10 of our
patients at the time of diagnosis, and in 7 additional patients
thereafter, were associated with more than 1 risk factor in our
patients (including cancer plus each of atrial ﬁbrillation,
endocarditis, hypertension, DM, malaria, or cerebral infarction
history, as well as DM plus a postoperative immobilization
state). Intensive anticoagulation therapy and careful probing
for underlying disease may be required to prevent concomitant
adverse thromboembolic events as suggested by Yun [10];
however, this could result in more adverse outcomes in certain
patients such as those with cancer. Infarctions in other organs
are not associated with renal function change.
This study has several limitations. We did not measure the
infarction size. We attempted tomeasure the infarction size but
faced technical limitations. In our institute, volumetry is only
available when using a special computed tomography protocol,which is different from the protocols we used. Furthermore, the
study was a retrospective, observational, and single-center
study, which would have led to bias in the data. For more ac-
curate measurements of inﬂammatory burdens, other cyto-
kines and biomarkers ought to be evaluated in addition to CRP.
More than one-third of our patients were excluded from CKD
analysis for various reasons as mentioned previously. Finally,
underlying conditions were not fully evaluated in some pa-
tients, especially those with idiopathic RI; hence, more exten-
sive investigation strategies are required in such cases. To
deﬁnitively determine if RI is a risk factor for CKD, a compar-
ative study by using propensity-matched healthy subjects is
advisable. Moreover, a multicenter large-scale study is neces-
sary to identify hidden risk factors for idiopathic RI.
In conclusion, we found that 34.8% of patients diagnosed
with RI also experienced AKI, and 27.1% experienced CKD dur-
ing the follow-up period. Most patients had clinical symptoms
and underlying risk factors. Risk factors for AKI were DM and
increased CRP levels, which may be indicative of severe dam-
age. Old age was a risk factor for CKD, whereas AKI was not a
risk factor for CKD. Medical therapy was sufﬁcient in most
cases. Some patients with multiple comorbidities also exhibi-
ted infarctions in other organs. Finally, AKI history is inversely
proportional to the deterioration of eGFR.Conﬂicts of interest
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